Amiodarone (tablet): Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
<small>'''''Brand Names | <small>'''''Synonyms / Brand Names:'''''</small> | ||
{{CMG}} | {{CMG}} | ||
==Dosing and Administration== | |||
<br> | |||
---- | |||
<br> | <br> | ||
<font size="4"> | <font size="4"> | ||
== | [[{{PAGENAME}}#FDA Package Insert Resources|FDA Package Insert Resources]] | ||
<br></font size><small>Indications, Contraindications, Side Effects, Drug Interactions, etc.</small><font size="4"><br> | |||
<br> | |||
[http://www.pace-med-apps.com/gfrcalc.htm Calculate Creatine Clearance] | |||
<br></font size><small>On line calculator of your patients Cr Cl by a variety of formulas.</small><font size="4"><br> | |||
<br> | |||
[http://home.earthlink.net/~sensei11/convert.htm Convert pounds to Kilograms] | |||
<br></font size><small>On line calculator of your patients weight in pounds to Kg for dosing estimates.</small><font size="4"><br> | |||
<br> [[{{PAGENAME}}#Publication Resources|Publication Resources]] | |||
<br></font size><small>Recent articles, WikiDoc State of the Art Review, Textbook Information</small><font size="4"><br> | |||
<br> | |||
[[{{PAGENAME}}#Trial Resources|Trial Resources]] | |||
<br></font size><small>Ongoing Trials, Trial Results</small><font size="4"><br> | |||
<br> | |||
[[{{PAGENAME}}#Guidelines & Evidence Based Medicine Resources|Guidelines & Evidence Based Medicine Resources]] | |||
<br></font size><small>US National Guidelines, Cochrane Collaboration, etc.</small><font size="4"><br> | |||
<br> | |||
[[{{PAGENAME}}#Media Resources|Media Resources]] | |||
<br></font size><small>Slides, Video, Images, MP3, Podcasts, etc.</small><font size="4"><br><br> | |||
[[{{PAGENAME}}#Patient Resources|Patient Resources]] | |||
<br></font size><small>Discussion Groups, Handouts, Blogs, News, etc.</small><font size="4"><br> | |||
<br> | |||
[[{{PAGENAME}}#International Resources|International Resources]] | |||
<br></font size><small>en Español</small><font size="4"><br> | |||
<br> | |||
---- | |||
<br> | |||
<br> | |||
<br> | <br> | ||
<br> | <br> | ||
[[ | |||
==FDA Package Insert Resources== | |||
[[{{PAGENAME}} indications|Indications]] | |||
<br> | <br> | ||
<br> | <br> | ||
[[ | [[{{PAGENAME}} contraindications|Contraindications]] | ||
<br> | <br> | ||
<br> | <br> | ||
[[ | [[{{PAGENAME}} side effects|Side Effects]] | ||
<br> | <br> | ||
<br> | <br> | ||
[[ | [[{{PAGENAME}} drug interactions|Drug Interactions]] | ||
<br> | <br> | ||
<br> | <br> | ||
[[ | [[{{PAGENAME}} precautions|Precautions]] | ||
<br> | <br> | ||
<br> | <br> | ||
[[ | [[{{PAGENAME}} overdose|Overdose]] | ||
<br> | <br> | ||
<br> | <br> | ||
[[ | [[{{PAGENAME}} instructions for administration|Instructions for Administration]] | ||
<br> | <br> | ||
<br> | <br> | ||
[[ | [[{{PAGENAME}} how supplied|How Supplied]] | ||
<br> | <br> | ||
<br> | <br> | ||
[[ | [[{{PAGENAME}} pharmacokinetics and molecular data|Pharmacokinetics and Molecular Data]] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [http://www.fda.gov/cder/foi/nda/99/75108_Nifedipine_prntlbl.pdf FDA label] | ||
<br> | <br> | ||
<br> | <br> | ||
Line 41: | Line 73: | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | |||
<br> | <br> | ||
<br> | <br> | ||
==Publication Resources== | |||
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} Most Recent Articles on {{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}] | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} Most Recent Articles on {{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}] | ||
<br> | <br> | ||
Line 51: | Line 84: | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+AND+%28%28N+Engl+J+Med%5Bta%5D%29+OR+%28Lancet%5Bta%5D%29+OR+%28BMJ%5Bta%5D%29%29 Articles on {{PAGENAME}} in N Eng J Med, Lancet, BMJ] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | [[{{PAGENAME}} detailed information|WikiDoc State of the Art Review]] | ||
<br> | <br> | ||
<br> | <br> | ||
Line 60: | Line 93: | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | |||
<br> | |||
<br> | |||
==Trial Resources== | |||
[http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} Ongoing Trials with {{PAGENAME}} at Clinical Trials.gov] | |||
<br> | <br> | ||
<br> | <br> | ||
[http:// | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+AND+%28randomized+controlled+trial%5BPublication+Type%5D+OR+%28randomized%5BTitle%2FAbstract%5D+AND+controlled%5BTitle%2FAbstract%5D+AND+trial%5BTitle%2FAbstract%5D%29%29 Trial Results with {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
[ | </font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | ||
<br> | <br> | ||
<br> | <br> | ||
==Guidelines & Evidence Based Medicine Resources== | |||
[http://www.guideline.gov/search/searchresults.aspx?Type=3&txtSearch={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&num=20 US National Guidelines Clearinghouse on {{PAGENAME}}] | [http://www.guideline.gov/search/searchresults.aspx?Type=3&txtSearch={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&num=20 US National Guidelines Clearinghouse on {{PAGENAME}}] | ||
<br> | <br> | ||
Line 82: | Line 115: | ||
<br> | <br> | ||
<br> | <br> | ||
[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term={{urlencode:({{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}) AND (Cost effectiveness)}} Cost | [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pubmed&term={{urlencode:({{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}) AND (Cost effectiveness)}} Cost Effectiveness of {{PAGENAME}}] | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | |||
<br> | <br> | ||
<br> | <br> | ||
[http://www.google.com/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+ppt&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a Powerpoint | ==Media Resources== | ||
[http://www.google.com/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+ppt&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a Powerpoint Slides on {{PAGENAME}}] | |||
<br> | <br> | ||
<br> | <br> | ||
Line 102: | Line 134: | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | |||
<br> | <br> | ||
<br> | <br> | ||
[[ | |||
==Patient Resources== | |||
[[{{PAGENAME}} (patient information)|Patient Information from National Library of Medicine]] | |||
<br> | <br> | ||
<br> | <br> | ||
Line 127: | Line 160: | ||
<br> | <br> | ||
<br> | <br> | ||
</font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | |||
<br> | |||
<br> | |||
==International Resources== | |||
[http://www.google.com/search?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}+en+espanol&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a {{PAGENAME}} en Español] | |||
<br> | <br> | ||
<br> | <br> | ||
[ | </font size><small>[[{{PAGENAME}}#Dosing and Administration|Return to top]]</small><font size="4"> | ||
<br> | <br> | ||
<br> | <br> | ||
</font size> | </font size> | ||
---- | |||
{{FDA}} | {{FDA}} | ||
[[Category:Drugs]] | [[Category:Drugs]] |
Revision as of 17:09, 8 January 2009
Synonyms / Brand Names:
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Dosing and Administration
FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.
Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.
Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.
Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information
Trial Resources
Ongoing Trials, Trial Results
Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.
Media Resources
Slides, Video, Images, MP3, Podcasts, etc.
Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.
International Resources
en Español
FDA Package Insert Resources
Indications
Contraindications
Side Effects
Drug Interactions
Precautions
Overdose
Instructions for Administration
How Supplied
Pharmacokinetics and Molecular Data
FDA label
FDA on Amiodarone (tablet)
Return to top
Publication Resources
Most Recent Articles on Amiodarone (tablet)
Review Articles on Amiodarone (tablet)
Articles on Amiodarone (tablet) in N Eng J Med, Lancet, BMJ
WikiDoc State of the Art Review
Textbook Information on Amiodarone (tablet)
Return to top
Trial Resources
Ongoing Trials with Amiodarone (tablet) at Clinical Trials.gov
Trial Results with Amiodarone (tablet)
Return to top
Guidelines & Evidence Based Medicine Resources
US National Guidelines Clearinghouse on Amiodarone (tablet)
Cochrane Collaboration on Amiodarone (tablet)
Cost Effectiveness of Amiodarone (tablet)
Return to top
Media Resources
Powerpoint Slides on Amiodarone (tablet)
Images of Amiodarone (tablet)
Podcasts & MP3s on Amiodarone (tablet)
Videos on Amiodarone (tablet)
Return to top
Patient Resources
Patient Information from National Library of Medicine
Patient Resources on Amiodarone (tablet)
Discussion Groups on Amiodarone (tablet)
Patient Handouts on Amiodarone (tablet)
Blogs on Amiodarone (tablet)
Amiodarone (tablet) in the News
Amiodarone (tablet) in the Marketplace
Return to top
International Resources
Amiodarone (tablet) en Español
Return to top
Adapted from the FDA Package Insert.